ObjectiveThis systematic review and meta-analysis aims to characterize the distribution of HIV-1 viral tropism at diagnosis among people living with HIV (PLWH) and examine its association with baseline CD4+ T lymphocyte counts, thereby providing an evi…
IntroductionEndothelial dysfunction is a recognized component of the pathogenesis and clinical course of inflammatory bowel disease (IBD). Measurement of soluble forms of cell adhesion molecules (CAMs) may reflect the extent of endothelial injury and s…
BackgroundPresurgical molecular therapy (PMT) including tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) showed various outcomes for renal cell carcinoma (RCC) with tumor thrombus (TT). We aimed to evaluate the impact of PMT on…
Non-coding RNAs (ncRNAs), comprising microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are increasingly recognized as central regulators of epigenetic programming in T lymphocytes with critical implications for immune tolerance and autoimmunity. W…
ObjectiveSubstantial progress has been made in understanding the involvement of malondialdehyde-acetaldehyde (MAA) adducts in rheumatoid arthritis (RA) pathogenesis. This systematic review synthesizes current evidence on the role of MAA-modified macrom…
BackgroundEmerging studies have investigated the association between acetaminophen (APAP) use and clinical outcomes in cancer patients receiving immune checkpoint inhibitors (ICIs), but their findings remain inconsistent. This meta-analysis aims to sys…
BackgroundThis umbrella review consolidates data from systematic reviews and meta-analyses on the efficacy and safety of Chimeric Antigen Receptor T-cell (CAR-T) therapy in hematologic malignancies. The aim is to assess CAR-T efficacy across different …
BackgroundThe integration of immune checkpoint inhibitors (ICIs) with perioperative chemotherapy (CT) has become a major focus of clinical research in resectable gastric or gastroesophageal junction (G/GEJ) cancer. Recent phase 2 and 3 trials have repo…
IntroductionThis meta-analysis was designed to compare the long-term outcomes of first-line programmed cell death protein 1 (PD-1) inhibitors plus chemotherapy versus chemotherapy in patients with advanced HER2-negative gastric cancer (GC).Materials an…
BackgroundThe TOPAZ-1 study results represented significant advancement in the treatment of advanced biliary tract cancer (BTC) by combining durvalumab with gemcitabine–cisplatin (DGC). However, the highly selected patient population may not reflect th…
